DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site

Abstract

Antibodies that neutralize autologous transmitted/founder (TF) HIV occur in most HIV-infected individuals and can evolve to neutralization breadth. Autologous neutralizing antibodies (nAbs) against neutralization-resistant (Tier-2) viruses are rarely induced by vaccination. Whereas broadly neutralizing antibody (bnAb)-HIV-Envelope structures have been defined, the structures of autologous nAbs have not. Here, we show that immunization with TF mutant Envs gp140 oligomers induced high-titer, V5-dependent plasma neutralization for a Tier-2 autologous TF evolved mutant virus. Structural analysis of autologous nAb DH427 revealed binding to V5, demonstrating the source of narrow nAb specificity and explaining the failure to acquire breadth. Thus, oligomeric TF Envs can elicit autologous nAbs to Tier-2 HIVs, but induction of bnAbs will require targeting of precursors of B cell lineages that can mature to heterologous neutralization.

Authors:
 [1];  [2];  [3];  [2];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [4];  [5];  [1];  [6] more »;  [1];  [1];  [1];  [1];  [7];  [2];  [8];  [1] « less
  1. Duke Univ. School of Medicine, Durham, NC (United States)
  2. Harvard Medical School, Boston, MA (United States)
  3. National Inst. for Communicable Diseases, Johannesburg (South Africa); Univ. of the Witwatersrand, Johannesburg (South Africa)
  4. Univ. of KwaZulu-Natal, Durban (South Africa); Columbia Univ., New York, NY (United States)
  5. Novartis Vaccines and Diagnostics, Inc., Cambridge, MA (United States)
  6. Boston Univ., MA (United States)
  7. National Inst. for Communicable Diseases, Johannesburg (South Africa); Univ. of KwaZulu-Natal, Durban (South Africa); Univ. of the Witwatersrand, Johannesburg (South Africa)
  8. Harvard Medical School, Boston, MA (United States); Howard Hughes Medical Inst., Boston, MA (United States)
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Org.:
NIH/NIAID/DAIDS
OSTI Identifier:
1234757
Grant/Contract Number:  
1F32AI116355-01
Resource Type:
Accepted Manuscript
Journal Name:
Cell Reports
Additional Journal Information:
Journal Volume: 14; Journal Issue: 1; Journal ID: ISSN 2211-1247
Publisher:
Elsevier
Country of Publication:
United States
Language:
ENGLISH
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Bradley, Todd, Fera, Daniela, Bhiman, Jinal, Eslamizar, Leila, Lu, Xiaozhi, Anasti, Kara, Zhang, Ruijung, Sutherland, Laura L., Scearce, Richard M., Bowman, Cindy M., Stolarchuk, Christina, Lloyd, Krissey E., Parks, Robert, Eaton, Amanda, Foulger, Andrew, Nie, Xiaoyan, Karim, Salim S. Abdool, Barnett, Susan, Kelsoe, Garnett, Kepler, Thomas B., Alam, S. Munir, Montefiori, David C., Moody, M. Anthony, Liao, Hua-Xin, Morris, Lynn, Santra, Sampa, Harrison, Stephen C., and Haynes, Barton F. Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site. United States: N. p., 2015. Web. doi:10.1016/j.celrep.2015.12.017.
Bradley, Todd, Fera, Daniela, Bhiman, Jinal, Eslamizar, Leila, Lu, Xiaozhi, Anasti, Kara, Zhang, Ruijung, Sutherland, Laura L., Scearce, Richard M., Bowman, Cindy M., Stolarchuk, Christina, Lloyd, Krissey E., Parks, Robert, Eaton, Amanda, Foulger, Andrew, Nie, Xiaoyan, Karim, Salim S. Abdool, Barnett, Susan, Kelsoe, Garnett, Kepler, Thomas B., Alam, S. Munir, Montefiori, David C., Moody, M. Anthony, Liao, Hua-Xin, Morris, Lynn, Santra, Sampa, Harrison, Stephen C., & Haynes, Barton F. Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site. United States. https://doi.org/10.1016/j.celrep.2015.12.017
Bradley, Todd, Fera, Daniela, Bhiman, Jinal, Eslamizar, Leila, Lu, Xiaozhi, Anasti, Kara, Zhang, Ruijung, Sutherland, Laura L., Scearce, Richard M., Bowman, Cindy M., Stolarchuk, Christina, Lloyd, Krissey E., Parks, Robert, Eaton, Amanda, Foulger, Andrew, Nie, Xiaoyan, Karim, Salim S. Abdool, Barnett, Susan, Kelsoe, Garnett, Kepler, Thomas B., Alam, S. Munir, Montefiori, David C., Moody, M. Anthony, Liao, Hua-Xin, Morris, Lynn, Santra, Sampa, Harrison, Stephen C., and Haynes, Barton F. Thu . "Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site". United States. https://doi.org/10.1016/j.celrep.2015.12.017. https://www.osti.gov/servlets/purl/1234757.
@article{osti_1234757,
title = {Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site},
author = {Bradley, Todd and Fera, Daniela and Bhiman, Jinal and Eslamizar, Leila and Lu, Xiaozhi and Anasti, Kara and Zhang, Ruijung and Sutherland, Laura L. and Scearce, Richard M. and Bowman, Cindy M. and Stolarchuk, Christina and Lloyd, Krissey E. and Parks, Robert and Eaton, Amanda and Foulger, Andrew and Nie, Xiaoyan and Karim, Salim S. Abdool and Barnett, Susan and Kelsoe, Garnett and Kepler, Thomas B. and Alam, S. Munir and Montefiori, David C. and Moody, M. Anthony and Liao, Hua-Xin and Morris, Lynn and Santra, Sampa and Harrison, Stephen C. and Haynes, Barton F.},
abstractNote = {Antibodies that neutralize autologous transmitted/founder (TF) HIV occur in most HIV-infected individuals and can evolve to neutralization breadth. Autologous neutralizing antibodies (nAbs) against neutralization-resistant (Tier-2) viruses are rarely induced by vaccination. Whereas broadly neutralizing antibody (bnAb)-HIV-Envelope structures have been defined, the structures of autologous nAbs have not. Here, we show that immunization with TF mutant Envs gp140 oligomers induced high-titer, V5-dependent plasma neutralization for a Tier-2 autologous TF evolved mutant virus. Structural analysis of autologous nAb DH427 revealed binding to V5, demonstrating the source of narrow nAb specificity and explaining the failure to acquire breadth. Thus, oligomeric TF Envs can elicit autologous nAbs to Tier-2 HIVs, but induction of bnAbs will require targeting of precursors of B cell lineages that can mature to heterologous neutralization.},
doi = {10.1016/j.celrep.2015.12.017},
journal = {Cell Reports},
number = 1,
volume = 14,
place = {United States},
year = {Thu Dec 24 00:00:00 EST 2015},
month = {Thu Dec 24 00:00:00 EST 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 39 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010

  • Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
  • DOI: 10.1107/S0907444909052925

Differential Reactivity of Germ Line Allelic Variants of a Broadly Neutralizing HIV-1 Antibody to a gp41 Fusion Intermediate Conformation
journal, September 2011

  • Alam, S. M.; Liao, H. -X.; Dennison, S. M.
  • Journal of Virology, Vol. 85, Issue 22
  • DOI: 10.1128/JVI.05680-11

Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape
journal, May 2012


Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
journal, July 2012


MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
journal, May 2007

  • Davis, I. W.; Leaver-Fay, A.; Chen, V. B.
  • Nucleic Acids Research, Vol. 35, Issue Web Server
  • DOI: 10.1093/nar/gkm216

Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables
journal, November 2009

  • Doria-Rose, N. A.; Klein, R. M.; Daniels, M. G.
  • Journal of Virology, Vol. 84, Issue 3
  • DOI: 10.1128/JVI.01482-09

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
journal, March 2014

  • Doria-Rose, Nicole A.; Schramm, Chaim A.; Gorman, Jason
  • Nature, Vol. 509, Issue 7498
  • DOI: 10.1038/nature13036

Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains
journal, June 2014

  • Fera, D.; Schmidt, A. G.; Haynes, B. F.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 28
  • DOI: 10.1073/pnas.1409954111

Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
journal, July 2014


A FAM21-Containing WASH Complex Regulates Retromer-Dependent Sorting
journal, November 2009


Host Controls of HIV Neutralizing Antibodies
journal, May 2014


Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
journal, October 2013


Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
journal, May 2008

  • Keele, B. F.; Giorgi, E. E.; Salazar-Gonzalez, J. F.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 21
  • DOI: 10.1073/pnas.0802203105

Immunoglobulin Gene Insertions and Deletions in the Affinity Maturation of HIV-1 Broadly Reactive Neutralizing Antibodies
journal, September 2014


Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
journal, September 2012


Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
journal, August 2013

  • Kwong, Peter D.; Mascola, John R.; Nabel, Gary J.
  • Nature Reviews Immunology, Vol. 13, Issue 9
  • DOI: 10.1038/nri3516

High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies
journal, June 2009


Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated
journal, October 2011

  • Liao, Hua-Xin; Chen, Xi; Munshaw, Supriya
  • The Journal of Experimental Medicine, Vol. 208, Issue 11
  • DOI: 10.1084/jem.20110363

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
journal, April 2013

  • Liao, Hua-Xin; Lynch, Rebecca; Zhou, Tongqing
  • Nature, Vol. 496, Issue 7446
  • DOI: 10.1038/nature12053

Antigenicity and Immunogenicity of Transmitted/Founder, Consensus, and Chronic Envelope Glycoproteins of Human Immunodeficiency Virus Type 1
journal, January 2013

  • Liao, H. -X.; Tsao, C. -Y.; Alam, S. M.
  • Journal of Virology, Vol. 87, Issue 8
  • DOI: 10.1128/JVI.02297-12

Molecular architecture of native HIV-1 gp120 trimers
journal, July 2008

  • Liu, Jun; Bartesaghi, Alberto; Borgnia, Mario J.
  • Nature, Vol. 455, Issue 7209
  • DOI: 10.1038/nature07159

HIV-1 neutralizing antibodies: understanding nature's pathways
journal, June 2013

  • Mascola, John R.; Haynes, Barton F.
  • Immunological Reviews, Vol. 254, Issue 1
  • DOI: 10.1111/imr.12075

Solving structures of protein complexes by molecular replacement with Phaser
journal, December 2006

  • McCoy, Airlie J.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 63, Issue 1
  • DOI: 10.1107/S0907444906045975

Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
journal, March 2013

  • McGuire, Andrew T.; Hoot, Sam; Dreyer, Anita M.
  • The Journal of Experimental Medicine, Vol. 210, Issue 4
  • DOI: 10.1084/jem.20122824

SoDA2: a Hidden Markov Model approach for identification of immunoglobulin rearrangements
journal, February 2010


[20] Processing of X-ray diffraction data collected in oscillation mode
book, January 1997


A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene
journal, January 2015

  • Pugach, Pavel; Ozorowski, Gabriel; Cupo, Albert
  • Journal of Virology, Vol. 89, Issue 6
  • DOI: 10.1128/JVI.03473-14

Rapid evolution of the neutralizing antibody response to HIV type 1 infection
journal, March 2003

  • Richman, D. D.; Wrin, T.; Little, S. J.
  • Proceedings of the National Academy of Sciences, Vol. 100, Issue 7
  • DOI: 10.1073/pnas.0630530100

HIV-1 neutralizing antibodies induced by native-like envelope trimers
journal, June 2015


Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
journal, July 2014

  • Sarzotti-Kelsoe, Marcella; Bailer, Robert T.; Turk, Ellen
  • Journal of Immunological Methods, Vol. 409
  • DOI: 10.1016/j.jim.2013.11.022

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
journal, March 2009

  • Scheid, Johannes F.; Mouquet, Hugo; Feldhahn, Niklas
  • Nature, Vol. 458, Issue 7238
  • DOI: 10.1038/nature07930

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
journal, July 2011


Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
journal, November 2009

  • Seaman, M. S.; Janes, H.; Hawkins, N.
  • Journal of Virology, Vol. 84, Issue 3
  • DOI: 10.1128/JVI.02108-09

Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals
journal, August 2011

  • Tomaras, G. D.; Binley, J. M.; Gray, E. S.
  • Journal of Virology, Vol. 85, Issue 21
  • DOI: 10.1128/JVI.05363-11

Broad neutralization coverage of HIV by multiple highly potent antibodies
journal, September 2011

  • Walker, Laura M.; Huber, Michael; Doores, Katie J.
  • Nature, Vol. 477, Issue 7365
  • DOI: 10.1038/nature10373

Antibody neutralization and escape by HIV-1
journal, March 2003

  • Wei, Xiping; Decker, Julie M.; Wang, Shuyi
  • Nature, Vol. 422, Issue 6929
  • DOI: 10.1038/nature01470

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
journal, June 1998


Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies
journal, January 2013

  • Yang, Guang; Holl, T. Matt; Liu, Yang
  • The Journal of Experimental Medicine, Vol. 210, Issue 2
  • DOI: 10.1084/jem.20121977

Structural definition of a conserved neutralization epitope on HIV-1 gp120
journal, February 2007


Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
journal, July 2010


Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies?
journal, November 1992


Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
journal, July 2014


Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
journal, September 2012


Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
journal, March 2009

  • Scheid, Johannes F.; Mouquet, Hugo; Feldhahn, Niklas
  • Nature, Vol. 458, Issue 7238
  • DOI: 10.1038/nature07930

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
journal, April 2013

  • Liao, Hua-Xin; Lynch, Rebecca; Zhou, Tongqing
  • Nature, Vol. 496, Issue 7446
  • DOI: 10.1038/nature12053

Rapid evolution of the neutralizing antibody response to HIV type 1 infection
journal, March 2003

  • Richman, D. D.; Wrin, T.; Little, S. J.
  • Proceedings of the National Academy of Sciences, Vol. 100, Issue 7
  • DOI: 10.1073/pnas.0630530100

Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains
journal, June 2014

  • Fera, D.; Schmidt, A. G.; Haynes, B. F.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 28
  • DOI: 10.1073/pnas.1409954111

Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated
journal, October 2011

  • Liao, Hua-Xin; Chen, Xi; Munshaw, Supriya
  • The Journal of Experimental Medicine, Vol. 208, Issue 11
  • DOI: 10.1084/jem.20110363

Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
journal, March 2013

  • McGuire, Andrew T.; Hoot, Sam; Dreyer, Anita M.
  • The Journal of Experimental Medicine, Vol. 210, Issue 4
  • DOI: 10.1084/jem.20122824

SoDA2: a Hidden Markov Model approach for identification of immunoglobulin rearrangements
journal, February 2010


Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
journal, October 2013


Host Controls of HIV Neutralizing Antibodies
journal, May 2014


Broad Neutralization of Human Immunodeficiency Virus Type 1 Mediated by Plasma Antibodies against the gp41 Membrane Proximal External Region
journal, August 2009

  • Gray, E. S.; Madiga, M. C.; Moore, P. L.
  • Journal of Virology, Vol. 83, Issue 21
  • DOI: 10.1128/jvi.01359-09

Taking Care of Unfinished Business and the Business of the 21st Century
journal, August 2012


MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
text, January 2007

  • B., Chen, Vincent; C., Richardson, David; S., Richardson, Jane
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/m2an-p252

Works referencing / citing this record:

Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
journal, January 2017

  • Borrow, Persephone; Moody, M. Anthony
  • Immunological Reviews, Vol. 275, Issue 1
  • DOI: 10.1111/imr.12504

Advances in HIV-1 Vaccine Development
journal, April 2018

  • Gao, Yong; McKay, Paul; Mann, Jamie
  • Viruses, Vol. 10, Issue 4
  • DOI: 10.3390/v10040167

Native-like Env trimers as a platform for HIV-1 vaccine design
journal, January 2017

  • Sanders, Rogier W.; Moore, John P.
  • Immunological Reviews, Vol. 275, Issue 1
  • DOI: 10.1111/imr.12481

Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization
journal, July 2016

  • Townsley, Samantha; Mohamed, Zeinab; Guo, Wenjin
  • Journal of Virology, Vol. 90, Issue 19
  • DOI: 10.1128/jvi.00853-16

HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
journal, November 2018


Quantification of the Resilience and Vulnerability of HIV-1 Native Glycan Shield at Atomistic Detail
journal, January 2020

  • Chakraborty, Srirupa; Berndsen, Zachary T.; Hengartner, Nicolas W.
  • SSRN Electronic Journal
  • DOI: 10.2139/ssrn.3606299

RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses
journal, October 2018


Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies
journal, August 2016


Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth
journal, October 2018


Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity
journal, October 2016


Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies
journal, January 2018


Identification and specificity of broadly neutralizing antibodies against HIV
journal, January 2017

  • McCoy, Laura E.; Burton, Dennis R.
  • Immunological Reviews, Vol. 275, Issue 1
  • DOI: 10.1111/imr.12484

Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
journal, January 2017

  • Borrow, Persephone; Moody, M. Anthony
  • Immunological Reviews, Vol. 275, Issue 1
  • DOI: 10.1111/imr.12504

Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs
journal, July 2018

  • Bricault, Christine A.; Kovacs, James M.; Badamchi-Zadeh, Alexander
  • Journal of Virology, Vol. 92, Issue 13
  • DOI: 10.1128/jvi.00369-18

HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
journal, November 2018


Advances in HIV-1 Vaccine Development
journal, April 2018

  • Gao, Yong; McKay, Paul; Mann, Jamie
  • Viruses, Vol. 10, Issue 4
  • DOI: 10.3390/v10040167